Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 110 (RNA5SP110)

Target
RNA5SP110
Molecular classification
Other (Pseudogene)
01

Overview

RNA, 5S ribosomal pseudogene 110 (RNA5SP110) is a **pseudogene** in the human genome. Pseudogenes are typically segments of DNA that resemble known genes but are non-functional due to various disabling mutations or truncations. Unlike functional 5S ribosomal RNAs (5S rRNAs), which are integral to ribosome structure and protein synthesis[1][5], this pseudogene does not produce a functional RNA molecule. There is no evidence it serves as a therapeutic target, plays a direct role in disease, or interacts with drugs. It can be used for evolutionary or phylogenetic studies but has no known physiological or pharmacological function in humans[2][4][6]. Key points and clarification: - RNA5SP110 is explicitly classified as a **pseudogene**, not an active gene, protein, or receptor[2]. - It is **not a drug target**, not a receptor, enzyme, transporter, or transcription factor, and no biological function is known for this locus as a pseudogene[2][4][6]. - Pseudogenes may sometimes play roles through RNA interference or as competitive endogenous RNAs, but there is no evidence for such functions for RNA5SP110 specifically[4]. - If this entry appears in a therapeutic target list, it is inappropriate: it is **not a valid or meaningful drug target** and is thus marked as **is_incorrect: true**. - The closest actual biological entity is "5S ribosomal RNA," a structural RNA of the ribosome, but RNA5SP110 is not a functional copy—thus, no molecular classification like "receptor" or "enzyme" is appropriate[1][2][5].

Other names
RN5S110RNA, 5S ribosomal 110RNA5SP110

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 110 (RNA5SP110).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 110 (RNA5SP110).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call